Healthtech Series A Investors & VC Firms
2310 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Sandbox Industries
ChicagoSeed–Growth
34 people
Tech Square Ventures
AtlantaPre-Seed–Series A$500K – $3M
14 people
Maverick Ventures
San FranciscoSeed–Series B$3M – $10M
10 people
Angel Physicians Fund
Pre-Seed–Series A
44 people
Astanor Ventures
BrusselsSeed–Growth
29 people
Advent Life Sciences
LondonSeed–Series C
28 people
Cambridge Angels group
CambridgePre-Seed–Series A$195K – $1.9M
5 people
LIFTT
TorinoPre-Seed–Growth
36 people
Kfund
MadridPre-Seed–Series B$108K – $10.8M
27 people
Deepbridge Capital
ChesterSeed–Series A
25 people
Sozo Ventures
Redwood CityPre-Seed–Late Stage
29 people
Defy Partners
WoodsidePre-Seed–Series A$3M – $10M
24 people
S3 Ventures
AustinSeed–Series B$500K – $15M
12 people
Gresham House Ventures
LondonSeed–Growth$1.3M – $26M
38 people
Colle Capital Partners
New YorkPre-Seed–Series A$500K – $2M
28 people
Good Growth Capital
CharlestonPre-Seed–Series A
31 people
Spider Capital
San FranciscoSeed–Series A$500K
15 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
15 people
Breyer Capital
AustinPre-Seed–Series A$500K – $10M
7 people
NV NOM
GroningenSeed–Growth
27 people
Aisling Capital
New YorkSeed–Series C
12 people
Norrsken VC
StockholmSeed–Series A$1.1M – $3.2M
24 people
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
Ventures Platform
AbujaPre-Seed–Series A$50K – $1M
22 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Healthtech Investors & VC Firms (4191)Series A Investors & VC Firms in United States (3839)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Healthtech Investors & VC Firms in United States (2437)Series A Investors & VC Firms in Europe (2384)
Data sourced from public filings and firms' own websites — see our methodology.
















































































































